Concentrix Corporation (CNXC) Misses Q2 EPS by 8c; offers guidance

Concentrix Corporation (NASDAQ: CNXC) reported Q2 EPS of $2.70, $0.08 worse than the analyst estimate of $2.78. Revenue for the quarter came in at $2.42 billion versus the consensus estimate of $2.38 billion.

GUIDANCE:

Concentrix Corporation sees Q3 2025 EPS of $2.80-$2.91, versus the consensus of $2.90. Concentrix Corporation sees Q3 2025 revenue of $2.445-2.47 billion, versus the consensus of $2.392 billion.

Concentrix Corporation sees FY2025 EPS of $11.53-$11.76, versus the consensus of $11.53. Concentrix Corporation sees FY2025 revenue of $9.72-9.815 billion, versus the consensus of $9.613 billion.

For earnings history and earnings-related data on Concentrix Corporation (CNXC) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• BuzzFeed sells shares to Byron Allen affiliate for $5.8 million